Bringing Innovative Treatments to Patients
Acadia Pharmaceuticals Inc., a biopharmaceutical company focused on advancing therapies in underserved neurological disorders and rare diseases, is inspired to bring lasting differences and brighter futures to patients and their loved ones around the world.
Click here to learn more about Rett syndrome.
Below are links to helpful resources for your practice and patients.
Materials for Healthcare Professionals
HCP Treatment Management Guide – This guide helps educate HCPs about initiating patients on the first and only FDA-approved, RTT-specific treatment. Includes information on potential changes in RTT signs and symptoms, potential side effect management, and helping patients get started.
Whitepaper: Rett Syndrome: Connecting Science, Clinical Practice and the Path Forward – This white paper offers HCPs critical insights into RTT, guiding them from early diagnosis based on subtle developmental regressions to understanding the unique neurobiology of RTT and the significant potential for patient improvements.
Materials for Your Patients and Caregivers
Treatment Overview Brochure – This brochure provides caregivers with balanced information about potential treatment benefits and side effects. It features caregiver stories to help give insight into the treatment experiences of others.
Getting Patients Started on Treatment – A resource to provide caregivers with a background on their RTT treatment and what to expect in the early stages of treatment initiation and beyond.
Acadia’s Commitment to Rett Syndrome
Acadia Therapeutic Areas | Rett Syndrome – Explore Rett syndrome with this webpage that provides helpful information for patients and caregivers, offering educational content, actionable resources, and updates for the Rett community. Acadia aims to empower families with knowledge and support for managing Rett syndrome.